The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback